CLINICAL STUDIES
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Robert G. Hart, MDa,
Lesly A. Pearce, MS ,
Robert M. Rothbart, MD, FACC ,
John H. McAnulty, MD, FACC ,
Richard W. Asinger, MD, FACC||,
Jonathan L. Halperin, MD, FACC¶ for the Stroke Prevention in Atrial Fibrillation Investigators
a University of Texas Health Science Center, San Antonio, Texas, USA
Axio Research Corporation, Seattle, Washington, USA
LeBauer Cardiology Associates, Greensboro, North Carolina, USA
Oregon Health Sciences University, Portland, Oregon, USA
|| Hennepin County Medical Center, Minneapolis, Minnesota, USA
¶ Mt. Sinai Medical Center, New York, New York, USA
Manuscript received March 4, 1999;
revised manuscript received July 8, 1999,
accepted September 10, 1999.
Reprint requests and correspondence: Dr. Robert G. Hart, Department of Medicine (Neurology), University of Texas HSC, 7703 Floyd Curl Drive, San Antonio, Texas 78284
HartR{at}uthscsa.edu
OBJECTIVE
This study was performed to characterize the risk of stroke in elderly patients with recurrent intermittent atrial fibrillation (AF).
BACKGROUND
Although intermittent AF is common, relatively little is known about the attendant risk of stroke.
METHODS
A longitudinal cohort study was performed comparing 460 participants with intermittent AF with 1,552 with sustained AF treated with aspirin in the Stroke Prevention in Atrial Fibrillation studies and followed for a mean of two years. Independent risk factors for ischemic stroke were identified by multivariate analysis.
RESULTS
Patients with intermittent AF were, on average, younger (66 vs. 70 years, p < 0.001), were more often women (37% vs. 26% p < 0.001) and less often had heart failure (11% vs. 21%, p < 0.001) than those with sustained AF. The annualized rate of ischemic stroke was similar for those with intermittent (3.2%) and sustained AF (3.3%). In patients with intermittent AF, independent predictors of ischemic stroke were advancing age (relative risk [RR] = 2.1 per decade, p < 0.001), hypertension (RR = 3.4, p = 0.003) and prior stroke (RR = 4.1, p = 0.01). Of those with intermittent AF predicted to be high risk (24%), the observed stroke rate was 7.8% per year (95% confidence interval 4.5 to 14).
CONCLUSIONS
In this large cohort of AF patients given aspirin, those with intermittent AF had stroke rates similar to patients with sustained AF and similar stroke risk factors. Many elderly patients with recurrent intermittent AF have substantial rates of stroke and likely benefit from anticoagulation. High-risk patients with intermittent AF can be identified using the same clinical criteria that apply to patients with sustained AF.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | CI | = confidence interval | | INR | = international normalized ratio | | RR | = relative risk | | SPAF | = Stroke Prevention in Atrial Fibrillation | | TIA | = transient ischemic attack |
|
This article has been cited by other articles:
|
|
|
|
 
K. Wachtell, R. B. Devereux, P. A. Lyle, P. M. Okin, and E. Gerdts
The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy
Therapeutic Advances in Cardiovascular Disease,
December 1, 2008;
2(6):
507 - 513.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. H. Tayal, M. Tian, K. M. Kelly, S. C. Jones, D. G. Wright, D. Singh, J. Jarouse, J. Brillman, S. Murali, and R. Gupta
Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke
Neurology,
November 18, 2008;
71(21):
1696 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, X. Wang, and W. Chen
Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
Stroke,
October 1, 2008;
39(10):
2736 - 2743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Meiltz, M. Zimmermann, P. Urban, A. Bloch, and on behalf of the Association of Cardiologists of t
Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world
Europace,
June 1, 2008;
10(6):
674 - 680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
546S - 592S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Y H Lip and C J Boos
Antithrombotic treatment in atrial fibrillation
Postgrad. Med. J.,
May 1, 2008;
84(991):
252 - 258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Nieuwlaat, T. Dinh, S. B. Olsson, A. J. Camm, A. Capucci, R. G. Tieleman, G. Y.H. Lip, H. J.G.M. Crijns, and on behalf of the Euro Heart Survey Investigators
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
Eur. Heart J.,
April 1, 2008;
29(7):
915 - 922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
January 29, 2008;
117(4):
e25 - e146.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Hohnloser, D. Pajitnev, J. Pogue, J. S. Healey, M. A. Pfeffer, S. Yusuf, S. J. Connolly, and for the ACTIVE W Investigators
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy: An ACTIVE W Substudy
J. Am. Coll. Cardiol.,
November 27, 2007;
50(22):
2156 - 2161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hughes, G.Y.H. Lip, and on behalf of the Guideline Development Group for t
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review
QJM,
October 1, 2007;
100(10):
599 - 607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Jais and D. L. Packer
Ablation vs. drug use for atrial fibrillation
Eur. Heart J. Suppl.,
September 1, 2007;
9(suppl_G):
G26 - G34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, and W. Chen
Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation
J. Am. Coll. Cardiol.,
July 24, 2007;
50(4):
309 - 315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-W. Siu, M.-H. Jim, H.-H. Ho, R. Miu, S. W.L. Lee, C.-P. Lau, and H.-F. Tse
Transient Atrial Fibrillation Complicating Acute Inferior Myocardial Infarction: Implications for Future Risk of Ischemic Stroke
Chest,
July 1, 2007;
132(1):
44 - 49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tsivgoulis, S. Vassilopoulou, and K. Spengos
Impact of Anticoagulation on Poststroke Mortality in Ischemic Stroke Patients With Atrial Fibrillation
Stroke,
July 1, 2007;
38(7):
e61 - e61.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
February 6, 2007;
115(5):
e69 - e171.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Kalra, G Y H Lip, and on behalf of the Guideline Development Group for t
Antithrombotic treatment in atrial fibrillation
Heart,
January 1, 2007;
93(1):
39 - 44.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Nieuwlaat, A. Capucci, G. Y.H. Lip, S. B. Olsson, M. H. Prins, F. H. Nieman, J. Lopez-Sendon, P. E. Vardas, E. Aliot, M. Santini, et al.
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
Eur. Heart J.,
December 2, 2006;
27(24):
3018 - 3026.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Monte, A. Macchia, F. Pellegrini, M. Romero, V. Lepore, A. D'Ettorre, M. Saugo, L. Tavazzi, and G. Tognoni
Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation
Eur. Heart J.,
September 2, 2006;
27(18):
2217 - 2223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
651 - 745.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
854 - 906.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
e149 - e246.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
e257 - e354.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
700 - 752.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J.,
August 2, 2006;
27(16):
1979 - 2030.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Friberg, N. Hammar, M. Ringh, H. Pettersson, and M. Rosenqvist
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
Eur. Heart J.,
August 2, 2006;
27(16):
1954 - 1964.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Y H Lip and A. Tello-Montoliu
Management of atrial fibrillation.
Heart,
August 1, 2006;
92(8):
1177 - 1182.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker
Corticosteroids and the risk of atrial fibrillation.
Arch Intern Med,
May 8, 2006;
166(9):
1016 - 1020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Y H Lip and C J Boos
Antithrombotic treatment in atrial fibrillation
Heart,
February 1, 2006;
92(2):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Boos, R. A. Anderson, and G. Y.H. Lip
Is atrial fibrillation an inflammatory disorder?
Eur. Heart J.,
January 2, 2006;
27(2):
136 - 149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Waldo, R. C. Becker, V. F. Tapson, K. J. Colgan, and for the NABOR Steering Committee
Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation
J. Am. Coll. Cardiol.,
November 1, 2005;
46(9):
1729 - 1736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Ostermayer, M. Reisman, P. H. Kramer, R. V. Matthews, W. A. Gray, P. C. Block, H. Omran, A. L. Bartorelli, P. Della Bella, C. Di Mario, et al.
Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation: Results From the International Multi-Center Feasibility Trials
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
9 - 14.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Marini, F. De Santis, S. Sacco, T. Russo, L. Olivieri, R. Totaro, and A. Carolei
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study
Stroke,
June 1, 2005;
36(6):
1115 - 1119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. O'Donnell, G. Agnelli, and J. I. Weitz
Emerging therapies for stroke prevention in atrial fibrillation
Eur. Heart J. Suppl.,
May 1, 2005;
7(suppl_C):
C19 - C27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker
Drug-induced atrial fibrillation
J. Am. Coll. Cardiol.,
December 7, 2004;
44(11):
2117 - 2124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Page
Newly Diagnosed Atrial Fibrillation
N. Engl. J. Med.,
December 2, 2004;
351(23):
2408 - 2416.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
429S - 456S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
Ann Intern Med,
December 16, 2003;
139(12):
1018 - 1033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Singer
A 60-Year-Old Woman With Atrial Fibrillation
JAMA,
October 22, 2003;
290(16):
2182 - 2189.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Wang, J. M. Massaro, D. Levy, R. S. Vasan, P. A. Wolf, R. B. D'Agostino, M. G. Larson, W. B. Kannel, and E. J. Benjamin
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community: The Framingham Heart Study
JAMA,
August 27, 2003;
290(8):
1049 - 1056.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Waldo
Stroke Prevention in Atrial Fibrillation
JAMA,
August 27, 2003;
290(8):
1093 - 1095.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. G. Hart, J. L. Halperin, L. A. Pearce, D. C. Anderson, R. A. Kronmal, R. McBride, E. Nasco, D. G. Sherman, R. L. Talbert, J. R. Marler, et al.
Lessons from the Stroke Prevention in Atrial Fibrillation Trials
Ann Intern Med,
May 20, 2003;
138(10):
831 - 838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Kuhlkamp, L. Seipel, E. C. Healy, K. Bhaskarabhatla, W. J. Manning, D. G. Wyse, I. C. Van Gelder, and H. J.G.M. Crijns
Atrial Fibrillation -- Rate versus Rhythm Control
N. Engl. J. Med.,
March 27, 2003;
348(13):
1284 - 1286.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. C. Van Gelder, V. E. Hagens, H. A. Bosker, J. H. Kingma, O. Kamp, T. Kingma, S. A. Said, J. I. Darmanata, A. J.M. Timmermans, J. G.P. Tijssen, et al.
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
N. Engl. J. Med.,
December 5, 2002;
347(23):
1834 - 1840.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Y H Lip, R. G Hart, and D. S G Conway
ABC of antithrombotic therapy: Antithrombotic therapy for atrial fibrillation
BMJ,
November 2, 2002;
325(7371):
1022 - 1025.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Straus, S. R. Majumdar, and F. A. McAlister
New Evidence for Stroke Prevention: Scientific Review
JAMA,
September 18, 2002;
288(11):
1388 - 1395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Agmon, B. K. Khandheria, F. Gentile, and J. B. Seward
Clinical and Echocardiographic Characteristics of Patients With Left Atrial Thrombus and Sinus Rhythm: Experience in 20 643 Consecutive Transesophageal Echocardiographic Examinations
Circulation,
January 1, 2002;
105(1):
27 - 31.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.Y.H. Lip and F.L. L. S. Hee
Paroxysmal atrial fibrillation
QJM,
December 1, 2001;
94(12):
665 - 678.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Circulation,
October 23, 2001;
104(17):
2118 - 2150.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J.,
October 2, 2001;
22(20):
1852 - 1923.
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
1231 - 1265.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Majeed, K Moser, and K Carroll
Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database
Heart,
September 1, 2001;
86(3):
284 - 288.
[Abstract]
[Full Text]
[PDF]
</ | |
